Petagene
PetaGene’s mission is to make genomics data cheaper, faster and better.
Petagene has raised €3.6M across 2 funding rounds from 1 investor, most recently a Series A round in Dec 2018. Based in Cambridge, UK; founded 2015; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€3.6M
€3,640,813
Funding rounds
2
Investors
1
distinct backers
Active since
2018-12
latest 2018-12
Funding by year
EUR raised per yearPetagene — funding by year — interactive chart.
Data table
| Petagene — funding by year | |
|---|---|
| 2018 | €3.6M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▲ 11y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2018-12-26 | Series A | €1.8M | Romulus Capital | View deal → |
| 2018-12-20 | Series A | €1.8M | Romulus Capital | View deal → |